Skip to main content
. 2007 Sep 11;111(1):402–410. doi: 10.1182/blood-2007-04-081703

Table 2.

Summary of clinical data for Hb-SS subjects

TRV 2.5 m/s or over (n = 17) TRV under 2.5 m/s (n = 23) P
Age, y (± SD) 35.1 (± 13.2) 29.6 (± 8.3) .14
Female, % 71 52 .24
WHO/NYHA Class, %
    I 52.9 60.9 .09
    II 17.7 34.8
    III 29.4 4.4
TRV, m/s (± SD) 2.59 (± 0.29) 1.98 (± 0.21) <.001
Hydroxyurea use, % 35.3 34.8 .97

WHO/NYHA indicates World Health Organization/New York Heart Association; and —, not applicable.